WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced an extended agreement to support the FDA’s use of the company’s WebSDMTM software. This follow-on agreement, which involves technical support for the WebSDM software for use by the FDA Center for Drug Evaluation and Research (CDER) review community, will help the FDA to continue to work effectively with electronic data submissions in standardized format.
